Commentary on: A call for better reporting of trials using surrogate primary endpoints
Alzheimers Dement (N Y)
.
2022 Jul 26;8(1):e12339.
doi: 10.1002/trc2.12339.
eCollection 2022.
Author
Jeffrey Cummings
1
Affiliation
1
Chambers-Gundy Center for Transformative Neuroscience Pam Quirk Brain Health and Biomarker Laboratory Department of Brain Health School of Integrated Health Sciences University of Nevada Las Vegas Las Vegas Nevada USA.
PMID:
35910669
PMCID:
PMC9323348
DOI:
10.1002/trc2.12339
No abstract available